New ground for Novo: Denmark's largest company just keeps getting bigger
Contact Novo Nordisk - How can we help you?
Novo Nordisk, the maker of Wegovy and Ozempic is now Europe's most valuable company | CNN Business
Novo Nordisk announces conclusion of U.S. federal investigation of marketing practices
Novo Nordisk, Flagship's forward-thinking partnership aims to treat cardiometabolic, rare diseases | Fierce Biotech
Novo Nordisk (NVO) Rides on Ozempic & Wegovy Amid Rivalry
Novo Nordisk logo and symbol, meaning, history, PNG
Novo Nordisk - Our Headquarters in Denmark has turned orange to mark #WorldPatientSafetyDay 🧡 Stay safe, everyone! | Facebook
Novo Nordisk Headquarters – ArcDog
Novo Nordisk builds R&D capacity in cardiovascular and liver diseases | Science | AAAS
Find a job
Novo Nordiskt to invest more than 17 billion DKK in manufacturing facilities - Nordic Life Science – the leading Nordic life science news service
Ozempic's Surging Popularity Has Novo Nordisk (NVO) Struggling to Meet Demand - Bloomberg
Wegovy, the newest weight loss drug, comes with a high cost - Los Angeles Times
Signal: Novo Nordisk market cap higher than Danish GDP due to obesity drugs - Pharmaceutical Technology
Ozempic maker Novo Nordisk to acquire obesity drug developer in $1B deal | The Hill
Novo Nordisk Foundation
Henning Larsen | Novo Nordisk Global Head Office
Novo Nordisk expands research collaboration in novel delivery technologies for biologic medicines | Science|Business
Novo Nordisk to invest $2.3bn to expand manufacturing facilities
Novo Nordisk Headquarters – ArcDog
Novo Nordisk Corporate Center | Architect Magazine
Novo Nordisk | Official Profile
